We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

213 hedge funds and large institutions have $528M invested in ARK Genomic Revolution ETF in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 39 increasing their positions, 69 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more capital invested

Capital invested by funds: $482M → $528M (+$45.6M)

6% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 33

0% less funds holding

Funds holding: 214 → 213 (-1)

7% less call options, than puts

Call options by funds: $107M | Put options by funds: $116M

3.25% less ownership

Funds ownership: 53.18% → 49.93% (-3.2%)

43% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 69

Holders
213
Holders Change
-1
Holders Change %
-0.47%
% of All Funds
2.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
39
Reduced
69
Closed
33
Calls
$107M
Puts
$116M
Net Calls
-$8.28M
Net Calls Change
-$21M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$20.2M
2
UBS Group
UBS Group
Switzerland
+$8.64M
3
Citadel Advisors
Citadel Advisors
Florida
+$8.36M
4
Wells Fargo
Wells Fargo
California
+$3.37M
5
Two Sigma Investments
Two Sigma Investments
New York
+$2.74M

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$41.4M
2
Bank of America
Bank of America
North Carolina
-$16.8M
3
Morgan Stanley
Morgan Stanley
New York
-$5.23M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$3.25M
5
SG Americas Securities
SG Americas Securities
New York
-$2.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
BT
151
Banque Transatlantique
France
$7.93K +$7.14K +326 New
BLC
152
Brown, Lisle/Cummings
Rhode Island
$7.91K – – –
AIM
153
Anchor Investment Management
South Carolina
$7.61K – – –
CLOS
154
Compagnie Lombard Odier SCmA
Switzerland
$7.55K – – –
SWM
155
Spire Wealth Management
Virginia
$7.5K – – –
DFA
156
DHJJ Financial Advisors
Illinois
$7.39K +$6.66K +304 New
ACM
157
Anfield Capital Management
California
$7.33K – – –
GWSG
158
GPS Wealth Strategies Group
Colorado
$6.84K -$5.39K -246 -47%
T
159
Tidemark
California
$6.75K – – –
WTFG
160
Wood Tarver Financial Group
Idaho
$6K -$1.97K -90 -24%
HI
161
Horizon Investments
North Carolina
$4.87K +$4.38K +200 New
CA
162
Clearstead Advisors
Ohio
$4.65K – – –
RWPA
163
Richard W. Paul & Associates
Michigan
$3.9K +$1.01K +46 +40%
TCA
164
Trifecta Capital Advisors
Illinois
$3.77K -$6.79K -310 -67%
SWA
165
SOA Wealth Advisors
New York
$3.77K -$3.4K -155 -50%
AF
166
Advisornet Financial
Minnesota
$3.65K – – –
MYIA
167
Mount Yale Investment Advisors
Colorado
$3.65K +$3.29K +150 New
TCOT
168
Trust Company of Toledo
Ohio
$3.65K +$3.29K +150 New
S
169
SignatureFD
Georgia
$3.36K – – –
AFG
170
Albion Financial Group
Utah
$3.36K – – –
APW
171
Aventura Private Wealth
Florida
$3.17K – – –
SS
172
Sunbelt Securities
Texas
$3.15K – – –
BBPWM
173
Blue Bell Private Wealth Management
Pennsylvania
$3.14K -$592 -27 -17%
PP
174
PrairieView Partners
Minnesota
$3K +$2.76K +126 New
MWM
175
MorganRosel Wealth Management
Colorado
$2.92K – – –
5 6
7
8 9

ARKG Hedge Fund Activity: Q2 2025 in Review

213 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2025, worth a combined $528M — up 9.5% from $482M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new ARKG positions and 33 closed out — a net gain of 2 holders — while 39 added to existing stakes and 69 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $20.2M. The largest seller was Citigroup, cutting an estimated $41.4M.

  • 213 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2025, down from 214 in Q1 2025.
  • Funds reported $528M of ARK Genomic Revolution ETF stock for Q2 2025, up 9.5% quarter-over-quarter.
  • 35 funds opened new ARK Genomic Revolution ETF positions in Q2 2025 and 33 closed out, a net change of +2 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q2 2025 was JP Morgan Chase, an estimated $20.2M added.
  • The largest ARK Genomic Revolution ETF seller in Q2 2025 was Citigroup, an estimated $41.4M sold.

Based on aggregated 13F filings for Q2 2025.